Infectious Disease

Pharmacist collaboration with physicians during a national shortage of intravenous trimethoprim/sulfamethoxazole may have helped mitigate negative treatment outcomes among HIV-infected patients with Pneumocystis jirovecii pneumonia.

The FDA today approved Bexsero, a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in patients aged 10 to 25 years.

Hospitalization for pneumonia increases a patient's risk of developing cardiovascular disease, according to a paper published in the January 20, 2015 edition of JAMA.

As we are all aware, the flu vaccine is not a perfect match this season.

Amiodarone has been shown to inhibit Ebola virus entry into host cells.

Evidence suggesting that this year's flu vaccine missed the mark has caused the CDC to turn to other treatment strategies.

Respiratory syncytial virus infection increases the risk of pneumonia in young children.

Rhinovirus infection tends to aggravate other conditions in the elderly.

Flu activity continued to worsen throughout the United States in the final week of 2014.

The FDA today granted the first waiver to allow the use of a nucleic acid-based influenza diagnostic test in a greater variety of health care settings.

Even intermittent heroin abuse can worsen human immunodeficiency virus infections.

Pregnant patients most often consult with pharmacists and other health care professionals on medications for psychiatric disorders and infectious diseases.

The role of pharmacists in HIV care across ambulatory care settings is expanding.

Joe Moose, PharmD, of Moose Pharmacy, discusses the role of the pharmacist in prevention and reducing readmissions among acute coronary syndrome patients.

While there are currently no active cases of Ebola virus infection in the United States, the US Centers for Disease Control and Prevention has announced that 35 hospitals across the country are now designated treatment centers for the virus.

A powdered measles vaccine delivered by a puff of air triggered no adverse side effects during early human testing, and future clinical trials will likely establish its efficacy.

A new Mayo Clinic study published in Microbiome shows that patients with acid reflux who regularly receive proton pump inhibitors have less diverse gut bacteria, which heightens their risk for bone fractures, vitamin deficiencies, and infections such as Clostridium difficile and pneumonia.

With a mission to help pharmacists throughout the world prevent the potential spread of the Ebola virus, the International Pharmaceutical Federation has launched a suite of resources to advise community pharmacists on the threat.

While the Ebola scare has started to fade away in the United States, the crisis continues to devastate West Africa, where the death toll has climbed above 5000 with more than 14000 confirmed and suspected cases.

Enhancing supportive care improves the chances of a patient surviving an Ebola infection.

A New York City physician who became infected with Ebola after treating patients in West Africa was released from the hospital after being declared virus free.

A study exploring Merck's experimental hepatitis C virus treatment has provided proof-of-concept for a 6- to 8-week course of triple therapy.

A potential Ebola outbreak in Senegal was snuffed out thanks in part to an innovative text-messaging program originally intended to help patients with diabetes manage their disease.

The World Health Organization is criticizing the drug industry for delaying the development of an Ebola vaccine.

The severe respiratory illness that infected more than 1000 children across the United States is starting to wane.

Astellas today announced that the FDA has granted orphan drug designation to isavuconazole for the treatment of invasive candidiasis, one of the most frequent invasive fungal infections detected in critically ill patients and a common cause of bloodstream infections.

Could the key to fighting modern illnesses lie in a disease that was an epidemic centuries ago?

New recommendations for the removal of protective gear highlight the need for enhanced technologies.

The FDA today approved the first vaccine licensed in the United States to prevent invasive serogroup B meningococcal disease in patients aged 10 to 25 years.

Federal officials are questioning state policies that mandate a 21-day quarantine of health care workers who treat Ebola patients.